Similar Articles
421 Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma
422 Radiomics and nomogram of magnetic resonance imaging for preoperative prediction of microvascular invasion in small hepatocellular carcinoma
423 Complete resection of large-cell neuroendocrine and hepatocellular carcinoma of the liver: A case report
424 Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching
425 RASSF1A methylation as a biomarker for detection of colorectal cancer and hepatocellular carcinoma
426 Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study
427 Prognostic role of expression of angiogenesis markers in hepatocellular carcinoma: A bioinformatics analysis
428 Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma
429 Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis
430 Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA